[HTML][HTML] Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell… - Journal of translational …, 2020 - Springer
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …

[PDF][PDF] Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell, MA Schreiber… - 2020 - scholar.archive.org
In late 2019, a novel coronavirus (SARS‑CoV‑2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS‑CoV‑2 infection quickly grew by several thousand per …

Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell… - Journal of …, 2020 - search.proquest.com
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …

[HTML][HTML] Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell… - Journal of …, 2020 - ncbi.nlm.nih.gov
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …

Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …

Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell… - Journal of …, 2020 - go.gale.com
Background In late December 2019, multiple cases of severe respiratory distress with an
unknown cause were reported in Wuhan, China. In January, a highly contagious novel …

Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell… - Journal of …, 2020 - ohsu.elsevierpure.com
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …

[PDF][PDF] Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell, MA Schreiber… - 2020 - scienceopen.com
In late 2019, a novel coronavirus (SARS‑CoV‑2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS‑CoV‑2 infection quickly grew by several thousand per …

[PDF][PDF] Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman, BA Bunnell, MA Schreiber… - 2020 - researchgate.net
In late 2019, a novel coronavirus (SARS‑CoV‑2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS‑CoV‑2 infection quickly grew by several thousand per …

[HTML][HTML] Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

CJ Rogers, RJ Harman… - Journal of …, 2020 - … -medicine.biomedcentral.com
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …